Florida becomes ninth state to sue Merck because of Vioxx
Pharma Compliance Alert, October 8, 2008
Add Florida to the list of states seeking money from Merck because of its withdrawn painkiller Vioxx.
The state alleges Merck deceptively marketed and promoted Vioxx by failing to disclose its side effects, according to an article in the South Florida Business Journal. According to the suit, Merck tried to intimidate physicians and researchers who questioned the safety of Vioxx, and may have misrepresented or concealed published evidence showing possible harmful side effects.
Merck took Vioxx off the market in 2004 after studies suggested the drug increased the risk of heart attack and stroke.
Alaska, Louisiana, Michigan, Mississippi, Montana, New York, Texas, and Utah have already sued the company. New York City filed suit as well.
Earlier this year, Merck entered into a $4.85 billion settlement with patients who claim they were harmed by Vioxx. The company also agreed to pay $58 million to settle claims by 29 states and the District of Columbia that it downplayed the risks of Vioxx in advertising.
Comments
0 comments on “Florida becomes ninth state to sue Merck because of Vioxx ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Healthcare Marketing Advisor
Healthcare Marketing Advisor provides concise, time-saving strategies for branding, promoting, and advertising your...
-
Marketing Oncology: Strategies for Service Line Campaigns
During this 90-minute Webcast, expert healthcare marketers discuss the research and strategic planning that should be the...
-
The Complete Guide to Hospital Marketing, Second Edition
The Complete Guide to Hospital Marketing, Second Edition looks at the complex field of healthcare marketing in a...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched